NEUTRA CORP. (NTRR) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US64129C3034

Price
0.00 USD
Market cap
291,789.91 USD
P/E (2026)
–
P/S (2026)
0.29
Dividend yield
0.00 %
Net margin
-0.68 %
Return on equity (ROE)
3.20 %
Return on assets (ROA)
-4.03 %

NEUTRA CORP. financials

Fiscal year20252026
Revenue68,057.00 USD1.02 m USD
Gross profit63,233.00 USD656,763.00 USD
Operating income-105,425.00 USD87,489.00 USD
Net income-109,023.00 USD-6,941.00 USD

Full history since 2010, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About NEUTRA CORP.

Neutra Corp. researches, develops, and provides hemp-derived products in the nutraceutical space in the United States. The company sells hemp-derived products, including products containing delta-8-THC and other cannabinoids, CBD sports creams, and other products. Neutra Corp. was incorporated in 2011 and is based in Houston, Texas.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.